Skip to content

Survey on adjuvant treatment pattern of hepatocellular carcinoma patients after curative surgery or ablation in China (SPHERE-E)

Survey on adjuvant treatment pattern of hepatocellular carcinoma patients after curative surgery or ablation in China (SPHERE-E)

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500096745
Enrollment
Unknown
Registered
2025-02-05
Start date
2025-02-17
Completion date
Unknown
Last updated
2025-02-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hepatocellular Carcinoma

Interventions

Observation Group:None

Sponsors

Shanghai Tenth People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. Currently working in a tertiary hospital; 2. More than 5 years of experience in radical surgery or adjuvant therapy after ablation for liver cancer, and have the title of chief physician or deputy chief physician (5 consultants must be chief physicians in first-tier cities); 3. Among the patients admitted in the past 3 months >=5 HCC patients underwent radical surgery or adjuvant therapy after ablation; 4. All eligible doctors need to sign the informed consent form (5 consulting doctors can not sign the informed consent form); 5. All inclusion criteria will be reviewed by the investigators or qualified designees to ensure that respondents are eligible to participate in the study.

Exclusion criteria

Exclusion criteria: No exclusion criteria

Design outcomes

Primary

MeasureTime frame
Different adjuvant treatment options distribution for patients after curative surgery or curative ablation;Consideration factors for different adjuvant treatment options;

Secondary

MeasureTime frame
Different systemic treatment in the adjuvant setting for patients after curative surgery or ablation;Consideration factors for different adjuvant systemic regimens;

Countries

China

Contacts

Public ContactLi Jun

Shanghai Tenth People's Hospital

lijundfgd@163.com+86 138 1765 4087

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026